Is Summit Biotech legit?
Summit Biotech is operating and surfaces credible public signals (composite 55/100), but we have not placed a first-hand test order yet — this is a public-data audit. Operator received an FDA warning letter on December 10, 2024 as "Summit Research Peptides," then rebranded to Summit Biotech without disclosing the prior identity on the new site. Login-walled catalog, code-name SKUs for the FDA-cited compounds, and the cheapest per-mg pricing in our seven-vendor index on Tirzepatide, Retatrutide, and Semaglutide. ~90% of COAs are real Janoshik public-database links. The signal table below shows what we verified and what is still open.
Signal table
What works, what does not
- +Cheapest per-mg pricing in our seven-vendor index on Tirzepatide ("T - 60mg" at $1.67/mg), Retatrutide ("R-10mg" at $5.50/mg), and Semaglutide ("Sema-1" at $5.00/mg)
- +Janoshik Analytical public-database COAs on 75 of 83 product records (~90%)
- +Catalog scale (40 in-stock SKUs at capture) covers the major research-peptide compounds — GLP-1 line, healing peptides, longevity stack
- +One transparent disclosure on the SS-31 listing ("Previously known as SS - 31") — at least one code-name is acknowledged on the page
- −Operator is the same entity that received an FDA warning letter on December 10, 2024 as Summit Research Peptides; rebrand to Summit Biotech is not disclosed on the new site
- −Login-walled catalog — no product, price, or COA is visible without registering an account
- −Code-name catalog for the FDA-cited compounds (Sema-1, R-10mg, T - 30mg, T - 60mg, Cagri, Tesa 20mg) and one acknowledged rebrand (**-31 / SS-31)
- −No public `/about-us`, `/privacy-policy`, or `/terms` page (all return 404 on the new domain)
- −No public LLC name, physical address, or business-entity registration visible on the site
- −Two of the Janoshik test URLs cited as Summit Biotech COAs (test IDs 93072 and 91848) also appear in the Peptopia community testing tracker against Geneza-style batch IDs — same physical batch, two different downstream sellers
What we mean by "legit"
We do not use "legit" as a single yes-or-no signal. A vendor is legit when four things hold: identifiable corporate operator, third-party or independently-mirrored COAs, shipping and payment infrastructure that consistently delivers, and a complaint history that surfaces real issues rather than vanishes them. Our composite score is the weighted average of those four — shipping, pricing, support, COA quality — and you can read the full rubric at /methodology.
For Summit Biotech the audit is "public-data tier" — we aggregate vendor disclosures, third-party COA mirrors, operating-history evidence, and complaint patterns. A first-hand test order is still pending and the page will be upgraded when that lands.
Verdict
Operator received an FDA warning letter on December 10, 2024 as "Summit Research Peptides," then rebranded to Summit Biotech without disclosing the prior identity on the new site. Login-walled catalog, code-name SKUs for the FDA-cited compounds, and the cheapest per-mg pricing in our seven-vendor index on Tirzepatide, Retatrutide, and Semaglutide. ~90% of COAs are real Janoshik public-database links.
Other audited vendors
Sources
- [01]FDA warning letter #695607 to Summit Research Peptides (Dec 2024)· FDA
- [02]FDA targets GLP-1 providers with warning letters· Foley & Lardner
- [03]Summit Biotech (current brand storefront)· vendor
- [04]Peptopia community testing tracker· Peptopia
- [05]Code-name catalogs and FDA evasion· vialaudit
- [06]Shared COA URLs and upstream supply· vialaudit
- [07]Janoshik 7,164-tests purity analysis· vialaudit
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.